EUVIMEDEUVIMED entdecken
Open Access

Correlates of Rotavirus Vaccine Shedding and Seroconversion in a US Cohort of Healthy Infants

Rachel M Burke iD, Daniel C Payne, Monica McNeal, Shannon C Conrey, Allison R Burrell, Claire P Mattison, Mary C Casey-Moore, Slavica Mijatovic-Rustempasic, Rashi Gautam, Mathew D Esona, Alexander W Thorman, Michael D Bowen und 4 weitere

The Journal of Infectious Diseases · 2024

DOI: 10.1093/infdis/jiae055 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2024. Verfasst von Rachel M Burke und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia. Hauptthemen laut MEDLINE: Rotavirus Vaccines, Virus Shedding, Antibodies, Viral, Rotavirus. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, PREVAIL, US Centers for Disease Control and Prevention.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Rotavirus is a leading cause of severe pediatric gastroenteritis; 2 highly effective vaccines are used in the United States (US). We aimed to identify correlates of immune response to rotavirus vaccination in a US cohort.

Methods

Pediatric Respiratory and Enteric Virus Acquisition and Immunogenesis Longitudinal (PREVAIL) is a birth cohort of 245 mother-child pairs enrolled in 2017–2018 and followed for 2 years. Infant stool samples and symptom information were collected weekly. Shedding was defined as reverse-transcription polymerase chain reaction detection of rotavirus vaccine virus in stools collected 4–28 days after dose 1. Seroconversion was defined as a 3-fold rise in immunoglobulin A between the 6-week and 6-month blood draws. Correlates were analyzed using generalized estimating equations and logistic regression.

Results

Prevaccination immunoglobulin G (IgG) (odds ratio [OR], 0.84 [95% confidence interval {CI}, .75–.94] per 100-unit increase) was negatively associated with shedding. Shedding was also less likely among infants with a single-nucleotide polymorphism inactivating FUT2 antigen secretion (“nonsecretors”) with nonsecretor mothers, versus all other combinations (OR, 0.37 [95% CI, .16–.83]). Of 141 infants with data, 105 (74%) seroconverted; 78 (77%) had shed vaccine virus following dose 1. Prevaccination IgG and secretor status were significantly associated with seroconversion. Neither shedding nor seroconversion significantly differed by vaccine product.

Conclusions

In this US cohort, prevaccination IgG and maternal and infant secretor status were associated with rotavirus vaccine response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rotavirus VaccinesVirus SheddingAntibodies, ViralRotavirusSeroconversionRotavirus InfectionsFecesImmunoglobulin GHumansInfantFemaleMaleUnited StatesImmunoglobulin ACohort StudiesLongitudinal StudiesBirth CohortAdultVaccination

Stichwörter der Autor:innen

histo-blood group antigens (HBGA)pediatric gastroenteritisrotavirusrotavirus vaccinevaccine immunogenicityvaccine responsevaccine shedding

Substanzen

Rotavirus VaccinesAntibodies, ViralImmunoglobulin GImmunoglobulin A

Autor:innen und Institutionen

  • Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Department of Pediatrics, University of Cincinnati College of Medicine.
  • Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center.
  • Department of Environmental and Public Health Sciences, University of Cincinnati College of Medicine, Cincinnati, Ohio.
  • Cherokee Nation Assurance, Arlington, Virginia.

ORCID-Profile: Rachel M Burke

Förderung

  • NIAID NIH HHS
  • PREVAIL
  • US Centers for Disease Control and Prevention
  • NCIRD CDC HHS
  • NIEHS NIH HHS
  • Intramural CDC HHS
  • NIH

Zitieren

APA

Burke, R. M., Payne, D. C., McNeal, M., Conrey, S. C., Burrell, A. R., Mattison, C. P., Casey-Moore, M. C., Mijatovic-Rustempasic, S., Gautam, R., Esona, M. D., Thorman, A. W., Bowen, M. D., Parashar, U. D., Tate, J. E., Morrow, A. L., & Staat, M. A. (2024). Correlates of Rotavirus Vaccine Shedding and Seroconversion in a US Cohort of Healthy Infants. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiae055

Vancouver

Burke RM, Payne DC, McNeal M, Conrey SC, Burrell AR, Mattison CP, et al. Correlates of Rotavirus Vaccine Shedding and Seroconversion in a US Cohort of Healthy Infants. The Journal of Infectious Diseases. 2024. doi:10.1093/infdis/jiae055

BibTeX
@article{Burke2024,
  author = {Burke, Rachel M and Payne, Daniel C and McNeal, Monica and Conrey, Shannon C and Burrell, Allison R and Mattison, Claire P and Casey-Moore, Mary C and Mijatovic-Rustempasic, Slavica and Gautam, Rashi and Esona, Mathew D and Thorman, Alexander W and Bowen, Michael D and Parashar, Umesh D and Tate, Jacqueline E and Morrow, Ardythe L and Staat, Mary A},
  title = {Correlates of Rotavirus Vaccine Shedding and Seroconversion in a US Cohort of Healthy Infants},
  journal = {The Journal of Infectious Diseases},
  year = {2024},
  doi = {10.1093/infdis/jiae055}
}
Kostenlos starten →